Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Status:
Completed
Trial end date:
1997-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone
sublingual tablet formulation as an office-based therapy for opiate dependence treatment.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of Pennsylvania
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone